Gastroenterology
Volume 129, Issue 6 , Pages 1928-1936 , December 2005

Coffee and Tea Consumption Are Associated With a Lower Incidence of Chronic Liver Disease in the United States

  • Constance E. Ruhl

      Affiliations

    • Social and Scientific Systems, Inc, Silver Spring, Maryland, USA
    • Corresponding Author InformationAddress requests for reprints to: Constance E. Ruhl, MD, PhD, Social and Scientific Systems, Inc, 8757 Georgia Avenue, 12th floor, Silver Spring, Maryland 20910. fax: (301) 628-3201.
    • ,
  • James E. Everhart

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland

Received 23 June 2005 ,Accepted 17 August 2005.

References 

  1. Ruhl CE , Everhart JE . Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States . Gastroenterology . 2005;128:24–32
  2. Arnesen E , Huseby NE , Brenn T , Try K . The Tromso Heart Study (distribution of, and determinants for, γ-glutamyltransferase in a free-living population) . Scand J Clin Lab Invest . 1986;46:63–70
  3. Nilssen O , Forde OH , Brenn T . The Tromso Study. Distribution and population determinants of γ-glutamyltransferase . Am J Epidemiol . 1990;132:318–326
  4. Casiglia E , Spolaore P , Ginocchio G , Ambrosio GB . Unexpected effects of coffee consumption on liver enzymes . Eur J Epidemiol . 1993;9:293–297
  5. Kono S , Shinchi K , Imanishi K , Todoroki I , Hatsuse K . Coffee and serum γ-glutamyltransferase (a study of self-defense officials in Japan) . Am J Epidemiol . 1994;139:723–727
  6. Pintus F , Mascia P . Distribution and population determinants of γ-glutamyltransferase in a random sample of Sardinian inhabitants. ATS-SARDEGNA Research Group . Eur J Epidemiol . 1996;12:71–76
  7. Poikolainen K , Vartiainen E . Determinants of γ-glutamyltransferase (positive interaction with alcohol and body mass index, negative association with coffee) . Am J Epidemiol . 1997;146:1019–1024
  8. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers . Int J Epidemiol . 1998;27:438–443
  9. Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee drinking and serum γ-glutamyltransferase (an extended study of Self-Defense Officials of Japan) . Ann Epidemiol . 1999;9:325–331
  10. Nakanishi N , Nakamura K , Nakajima K , Suzuki K , Tatara K . Coffee consumption and decreased serum γ-glutamyltransferase (a study of middle-aged Japanese men) . Eur J Epidemiol . 2000;16:419–423
  11. Nakanishi N , Nakamura K , Suzuki K , Tatara K . Lifestyle and the development of increased serum γ-glutamyltransferase in middle-aged Japanese men . Scand J Clin Lab Invest . 2000;60:429–438
  12. Nakanishi N , Nakamura K , Suzuki K , Tatara K . Lifestyle and serum γ-glutamyltransferase (a study of middle-aged Japanese men) . Occup Med . 2000;50:115–120 (Lond)
  13. Nakanishi N , Nakamura K , Suzuki K , Tatara K . Effects of coffee consumption against the development of liver dysfunction (a 4-year follow-up study of middle-aged Japanese male office workers) . Ind Health . 2000;38:99–102
  14. Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men . J Clin Epidemiol . 2001;54:823–829
  15. Klatsky AL , Armstrong MA . Alcohol, smoking, coffee, and cirrhosis . Am J Epidemiol . 1992;136:1248–1257
  16. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D’Amicis A, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study . Eur J Epidemiol . 1994;10:657–664
  17. Corrao G , Zambon A , Bagnardi V , D’Amicis A , Klatsky A . Coffee, caffeine, and the risk of liver cirrhosis . Ann Epidemiol . 2001;11:458–465
  18. Gallus S , Tavani A , Negri E , La Vecchia C . Does coffee protect against liver cirrhosis? . Ann Epidemiol . 2002;12:202–205
  19. Tverdal A , Skurtveit S . Coffee intake and mortality from liver cirrhosis . Ann Epidemiol . 2003;13:419–423
  20. Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology (a case-control study) . J Hepatol . 2005;42:528–534
  21. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, et al. Coffee consumption and the risk of primary liver cancer (pooled analysis of two prospective studies in Japan) . Int J Cancer . 2005;116:150–154
  22. Inoue M , Yoshimi I , Sobue T , Tsugane S . Influence of coffee drinking on subsequent risk of hepatocellular carcinoma (a prospective study in Japan) . J Natl Cancer Inst . 2005;97:293–300
  23. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, et al. Does coffee protect against hepatocellular carcinoma? . Br J Cancer . 2002;87:956–959
  24. La Vecchia C, Ferraroni M, Negri E, D’Avanzo B, Decarli A, Levi F, et al. Coffee consumption and digestive tract cancers . Cancer Res . 1989;49:1049–1051
  25. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma . Int J Cancer . 2000;85:498–502
  26. Miller HW . Plan and operation of the health and nutrition examination survey, United States 1971-1973, part A—development, plan, and operation . Hyattsville, MD: National Center for Health Statistics; 1973; Vital and health statistics, series 1, No. 10a. DHEW publication No. (PHS) 76-1310
  27. Engel A , Murphy RS , Maurer K , Collins E . Plan and operation of the NHANES I Augmentation Survey of adults 25-74 years, United States 1974-1975 . Hyattsville, MD: National Center for Health Statistics; 1978; Vital and health statistics, series 1, No. 14. DHEW publication No. (PHS) 78-1314
  28. NHANES I hematology and clinical chemistry procedures developed or utilized by the Center for Disease Control, Bureau of Laboratories, 1971-1975, instruction manual, data collection, part 16 . Washington, DC: US Government Printing Office; 1979;
  29. Cohen BB, Barbano HE, Cox CS, Feldman JJ, Finucane FF, Kleinman JC, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1982-84 . Hyattsville, MD: National Center for Health Statistics; 1987; Vital and health statistics, series 1, No. 22. DHEW publication No. (PHS) 87-1324
  30. Finucane FF, Freid VM, Madans JH, Cox CS, Kleinman JC, Rothwell ST, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1986 . Hyattsville, MD: National Center for Health Statistics; 1987; Vital and health statistics, series 1, No. 25. DHEW publication No. (PHS) 90-1307
  31. Cox CS, Rothwell ST, Madans JH, Finucane FF, Freid VM, Kleinman JC, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1987 . Hyattsville, MD: National Center for Health Statistics; 1992; Vital and health statistics, series 1, No. 27. DHEW publication No. (PHS) 92-1303
  32. Cox CS, Mussolino ME, Rothwell ST, Lane MA, Golden CD, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1992 . Hyattsville, MD: National Center for Health Statistics; 1997; Vital and health statistics, series 1, No. 35. DHEW publication No. (PHS) 98-1311
  33. International classification of diseases . 4th ed.. Washington, DC: US Government Printing Office; 1991; 9th rev. Clinical modification. Vol. 1, diseases: tabular list. DHHS publication No. (PHS) 91-1260
  34. Kleinbaum DG . Survival analysis (a self-learning text) . New York, NY: Springer; 1996;
  35. Ingram DD , Makuc DM . Statistical issues in analyzing the NHANES I Epidemiologic Follow-up Study . Hyattsville, MD: National Center for Health Statistics; 1994; Vital and health statistics, series 2, No. 121. DHHS publication No. (PHS) 94-1395.
  36. Michels KB , Willett WC , Fuchs CS , Giovannucci E . Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer . J Natl Cancer Inst . 2005;97:282–292
  37. Hasegawa M , Yamada S , Hirayama C . Fasting plasma caffeine level in cirrhotic patients (relation to plasma levels of catecholamines and renin activity) . Hepatology . 1989;10:973–977
  38. Cheng WS , Murphy TL , Smith MT , Cooksley WG , Halliday JW , Powell LW . Dose-dependent pharmacokinetics of caffeine in humans (relevance as a test of quantitative liver function) . Clin Pharmacol Ther . 1990;47:516–524
  39. He P , Noda Y , Sugiyama K . Suppression of lipopolysaccharide-induced liver injury by various types of tea and coffee in D-galactosamine-sensitized rats . Biosci Biotechnol Biochem . 2001;65:670–673
  40. Huber WW, Scharf G, Rossmanith W, Prustomersky S, Grasl-Kraupp B, Peter B, et al. The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat . Arch Toxicol . 2002;75:685–694
  41. Scharf G , Prustomersky S , Huber WW . Elevation of glutathione levels by coffee components and its potential mechanisms . Adv Exp Med Biol . 2001;500:535–539
  42. Lee KG , Mitchell A , Shibamoto T . Antioxidative activities of aroma extracts isolated from natural plants . Biofactors . 2000;13:173–178
  43. van Dam RM , Hu FB . Coffee consumption and risk of type 2 diabetes (a systematic review) . JAMA . 2005;294:97–104
  44. MacMahon B , Yen S , Trichopoulos D , Warren K , Nardi G . Coffee and cancer of the pancreas . N Engl J Med . 1981;304:630–633

 Supported by a contract from the National Institute of Diabetes and Digestive and Kidney Diseases (N01-DK-1-2478).

PII: S0016-5085(05)01774-9

doi: 10.1053/j.gastro.2005.08.056

Gastroenterology
Volume 129, Issue 6 , Pages 1928-1936 , December 2005

Article Tools

* Image Usage & Resolution